Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA

Official title: Effects of Different Stiffness Settings on Isokinetic Quadriceps Training in Children With Spinal Muscular Atrophy: A Randomized Within-Participant, Contralateral-Limb-Controlled Trial

Run by Peking University Third Hospital · NCT07822711 · Data updated 2026-11-12

This study tests whether a portable knee-training robot with a compliant vs. rigid stiffness setting improves knee strength in children with spinal muscular atrophy, using each child’s other leg as a comparison.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment13 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedOctober 22, 2026
Main results expectedJanuary 15, 2027
Study endsJanuary 30, 2027
Registry record updatedOctober 23, 2026
Trial IDNCT07822711 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6 to 12 years with spinal muscular atrophy who can sit independently and have stable disease-modifying treatment if applicable.

Probably not a fit

Children who cannot tolerate MRI/EMG, have uncontrolled blood pressure, or have other conditions limiting safe participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, within-subject trial compares two stiffness settings (compliant and rigid) of a portable isokinetic knee training robot in children with spinal muscular atrophy. Each participant has one leg trained with the compliant setting and the other with the rigid setting, over up to 8 weeks with the same training volume. Primary outcome is the difference between settings in change from baseline for peak knee-extension torque, with secondary outcomes including range of motion, quadriceps size by MRI, femoral nerve conduction, and sit-to-stand performance. The study also monitors knee pain, skin temperature, fatigue, and other adverse events; enrollment targets at least 13 participants aged 6–12 years. Randomization uses sealed envelopes and the trial is open-label. Eligibility requires SMA diagnosis, age 6–12, ability to sit independently, and stable disease-modifying therapy if applicable.

Why it matters

Potential benefit: If successful, the approach could identify an optimal stiffness setting to maximize knee strength gains during robot-assisted training for children with SMA.

How similar studies have gone: Prior work with a portable robotic knee trainer in SMA has shown safety and measurable training effects, supporting exploration of stiffness as a modifiable factor.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 6 to 12 years.
2. Diagnosis of spinal muscular atrophy.
3. Able to maintain an independent seated position.
4. If receiving disease-modifying treatment, including nusinersen or risdiplam, the participant must have received a stable dose for at least 6 months before enrollment and must not change the treatment regimen during the study.

Exclusion Criteria:

1. Any other major disease or medical condition that, in the investigator's judgment, would interfere with safe participation or interpretation of the study results.
2. The legal guardian declines to provide written informed consent, or the participant is unable to complete the study procedures.
3. Unable to undergo magnetic resonance imaging or electromyography and nerve conduction testing.
4. Blood pressure above the 95th percentile for age, sex, and height, as assessed by a clinician.
5. Lacks the cognitive capacity to understand or comply with the requirements of study participation.

Where it's running

  • Peking University Third Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.